Charles Schwab’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Charles Schwab’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,686	Closed	-$91.6K	–	3617
2022 Q4	$91.6K	Hold	15,686	–	–	﹤0.01%	3271
2022 Q3	$106K	Buy	+15,686	New	+$106K	﹤0.01%	3218
2022 Q2	–	Sell	-23,681	Closed	-$80K	–	3697
2022 Q1	$80K	Buy	+23,681	New	+$80K	﹤0.01%	3453
2021 Q3	–	Sell	-10,357	Closed	-$44K	–	3565
2021 Q2	$44K	Sell	10,357 -65,111	-86%	-$277K	﹤0.01%	3387
2021 Q1	$377K	Buy	75,468 +3,500	+5%	+$17.5K	﹤0.01%	3174
2020 Q4	$910K	Buy	71,968 +2,143	+3%	+$27.1K	﹤0.01%	2806
2020 Q3	$686K	Sell	69,825 -2,173	-3%	-$21.3K	﹤0.01%	2789
2020 Q2	$717K	Buy	71,998 +4,873	+7%	+$48.5K	﹤0.01%	2719
2020 Q1	$594K	Buy	67,125 +15,823	+31%	+$140K	﹤0.01%	2654
2019 Q4	$474K	Buy	51,302 +2,475	+5%	+$22.9K	﹤0.01%	2831
2019 Q3	$288K	Hold	48,827	–	–	﹤0.01%	2976
2019 Q2	$586K	Buy	48,827 +2,658	+6%	+$31.9K	﹤0.01%	2740
2019 Q1	$558K	Buy	46,169 +1,529	+3%	+$18.5K	﹤0.01%	2724
2018 Q4	$561K	Sell	44,640 -50,547	-53%	-$635K	﹤0.01%	2721
2018 Q3	$1.41M	Hold	95,187	–	–	﹤0.01%	2522
2018 Q2	$1.6M	Buy	95,187 +7,500	+9%	+$126K	﹤0.01%	2435
2018 Q1	$2.01M	Buy	87,687 +51,066	+139%	+$1.17M	﹤0.01%	2330
2017 Q4	$948K	Buy	36,621 +4,499	+14%	+$116K	﹤0.01%	2519
2017 Q3	$474K	Hold	32,122	–	–	﹤0.01%	2732
2017 Q2	$449K	Buy	32,122 +10,400	+48%	+$145K	﹤0.01%	2726
2017 Q1	$371K	Hold	21,722	–	–	﹤0.01%	2750
2016 Q4	$224K	Hold	21,722	–	–	﹤0.01%	2937
2016 Q3	$220K	Sell	21,722 -17,504	-45%	-$177K	﹤0.01%	2897
2016 Q2	$441K	Hold	39,226	–	–	﹤0.01%	2632
2016 Q1	$536K	Buy	39,226 +9,547	+32%	+$130K	﹤0.01%	2552
2015 Q4	$564K	Hold	29,679	–	–	﹤0.01%	2603
2015 Q3	$558K	Buy	29,679 +7,957	+37%	+$150K	﹤0.01%	2581
2015 Q2	$324K	Buy	+21,722	New	+$324K	﹤0.01%	2839